Delta Financial Group Inc. Makes New $492,000 Investment in Church & Dwight Co., Inc. (NYSE:CHD)

Delta Financial Group Inc. bought a new stake in shares of Church & Dwight Co., Inc. (NYSE:CHD) during the 4th quarter, HoldingsChannel.com reports. The firm bought 4,696 shares of the company’s stock, valued at approximately $492,000.

Several other institutional investors have also made changes to their positions in the business. Wealthspire Advisors LLC boosted its position in shares of Church & Dwight by 5.2% during the 4th quarter. Wealthspire Advisors LLC now owns 5,396 shares of the company’s stock valued at $565,000 after acquiring an additional 267 shares in the last quarter. Sigma Planning Corp boosted its position in Church & Dwight by 2.7% in the fourth quarter. Sigma Planning Corp now owns 5,178 shares of the company’s stock valued at $542,000 after buying an additional 137 shares in the last quarter. Redmond Asset Management LLC boosted its position in Church & Dwight by 311.1% in the fourth quarter. Redmond Asset Management LLC now owns 17,189 shares of the company’s stock valued at $1,800,000 after buying an additional 13,008 shares in the last quarter. Bradley Foster & Sargent Inc. CT boosted its position in Church & Dwight by 1.1% in the fourth quarter. Bradley Foster & Sargent Inc. CT now owns 15,515 shares of the company’s stock valued at $1,625,000 after buying an additional 168 shares in the last quarter. Finally, Nicholson Wealth Management Group LLC boosted its position in Church & Dwight by 110.0% in the fourth quarter. Nicholson Wealth Management Group LLC now owns 14,590 shares of the company’s stock valued at $1,528,000 after buying an additional 7,642 shares in the last quarter. 86.60% of the stock is currently owned by institutional investors and hedge funds.

Church & Dwight Stock Up 0.9 %

NYSE:CHD opened at $105.40 on Friday. The stock has a 50-day simple moving average of $105.35 and a 200 day simple moving average of $104.72. Church & Dwight Co., Inc. has a 52-week low of $96.35 and a 52-week high of $113.50. The company has a market cap of $25.93 billion, a PE ratio of 44.47, a PEG ratio of 3.32 and a beta of 0.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70.

Church & Dwight (NYSE:CHD) last announced its earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same period last year, the firm posted $0.65 EPS. On average, sell-side analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Friday, February 14th will be given a dividend of $0.295 per share. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.28. The ex-dividend date is Friday, February 14th. This represents a $1.18 annualized dividend and a dividend yield of 1.12%. Church & Dwight’s payout ratio is 49.79%.

Analyst Ratings Changes

A number of brokerages have weighed in on CHD. Stifel Nicolaus boosted their target price on shares of Church & Dwight from $103.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday, February 3rd. JPMorgan Chase & Co. dropped their price target on shares of Church & Dwight from $107.00 to $106.00 and set an “underweight” rating for the company in a research note on Friday. Barclays boosted their price target on shares of Church & Dwight from $90.00 to $93.00 and gave the stock an “underweight” rating in a research note on Tuesday, February 4th. Piper Sandler dropped their price target on shares of Church & Dwight from $128.00 to $126.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Finally, Wells Fargo & Company boosted their price target on shares of Church & Dwight from $113.00 to $115.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $111.47.

Insiders Place Their Bets

In related news, EVP Michael Read purchased 1,100 shares of the stock in a transaction on Monday, December 16th. The shares were purchased at an average price of $106.82 per share, with a total value of $117,502.00. Following the transaction, the executive vice president now directly owns 2,505 shares of the company’s stock, valued at $267,584.10. This trade represents a 78.29 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $106.11, for a total value of $1,061,100.00. Following the transaction, the director now directly owns 32,500 shares in the company, valued at $3,448,575. This trade represents a 23.53 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 49,522 shares of company stock valued at $5,487,555 in the last 90 days. 2.00% of the stock is currently owned by insiders.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.